New Pick: Breast Cancer Screening Tech That Saves Lives
By Andy Gordon on October 20, 2022
Note: This recommendation was co-authored by KingsCrowd Investment Research Associate Inez Sanjaya. The first time I learned that mammograms were incredibly painful was the first time Cecily got one after we got married. I guess this is something mothers don’t tell their sons but expound at length to their daughters about. I was clueless (not the first time, Cecily insists, and not the last). So when she…
Portfolio Update: Monogram Orthopaedics Explores a Public Listing
By Teddy Lyons on August 18, 2022
We recommended Monogram Orthopaedics to you back in 2019 and again in 2021. The company is developing advanced robotics technology combined with 3D printing to disrupt the joint replacement industry. We recently caught up with Monogram CEO Benjamin…
New Pick: This Noninvasive Glucose Monitoring Solution Could Help 422 Million People
By Andy Gordon on February 10, 2022
I worry a lot about Mark, Liz and Julia. Mark was my flatmate in London in 1975, and we’ve kept in close touch ever since. Liz and Julia are my sisters-in-law. They all have diabetes. I already lost a dear friend to diabetes last year. I don’t want…
Take Advantage of the Golden Age of Medtech Investing
By Vin Narayanan on February 8, 2022
A basic market inefficiency has created a massive opportunity for startup investors interested in medical technology and drug development startups. And angel investors savvy enough to understand what’s going on have a rare opportunity to invest in medtech startups with massive upside that have been significantly…
New Pick: Revolutionary Prosthesis Technology That Competitors Can’t Touch
By Andy Gordon on January 27, 2022
Lots of sectors are broken: banking, housing, education, day care and infrastructure. But none of these are as broken as the physical disability space. Fewer than one out of five arm amputees who need prosthetics actually use them. Available prosthetics are too heavy, clumsy and uncomfortable. They’re super…
Startup Insider: Filling the Biopharma Funding Gap
By Early Investing on July 12, 2021
There’s a funding gap in medical research known as the “valley of death.” When research begins, it’s funded by government grants and nonprofits. But drug research and development is very time-intensive. It typically takes around 10 years to bring a drug to market — and nine…
Startup Insider: Post-Pandemic Trends
By Early Investing on November 30, 2020
We finally have some good news on the COVID-19 front! It looks like the FDA will approve two vaccines shortly. And that by May or June of next year, we will start getting back to “normal.” So what does normal mean for startup investors? Which consumer…
News Fix: Bitcoin Network Surpasses Another Milestone
By Allison Brickell on August 10, 2019
In the news this week, bitcoin strengthens its security, Oklahoma marijuana dispensaries sue Facebook, and Lyft ends its lockup period early.
What Cannabis Businesses Need to Learn From Curaleaf and Icarus
By Vin Narayanan on August 9, 2019
Cannabis businesses need to learn from Icarus: Don’t fly too close to the sun. It could be your downfall.
News Fix: FDA Warns Curaleaf About Health Claims
By Vin Narayanan on July 27, 2019
In the news this week, the FDA sends Curaleaf a warning letter, Toyota invests in Didi and Steven Mnuchin is still salty about bitcoin.
Cannabis Report: Illinois Legalizes Recreational Marijuana, FDA Talks CBD
By Early Investing on June 6, 2019
There’s big news out of Illinois and the FDA this week. Illinois legalized recreational marijuana and the FDA had a hearing on CBD regulations.
Cannabis Report: Demand the Government Do Better
By Early Investing on March 28, 2019
The nascent cannabis industry is very reliant on the government in order to succeed. So the government needs to get it together.
News Fix: The Fed – and the Feds – Are Confused
By Vin Narayanan on March 23, 2019
In this week's News Fix, the Fed rolls over, the FDA passes the CBD buck to Congress and startup fever is catching.